Co-delivery of viral proteins and a TLR7 agonist from polysaccharide nanocapsules: a needle-free vaccination strategy.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Controlled Release

• Publication date

  2013-12-28

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.jconrel.2013.09.012PMID 24076340
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cubosomes containing the adjuvants imiquimod and monophosphoryl lipid A stimulate robust cellular and humoral immune responses.

  2013cited by this paper
• A Polymer/Oil Based Nanovaccine as a Single-Dose Immunization Approach

  2013influential reference
• Nano-particle vaccination combined with TLR-7 and -9 ligands triggers memory and effector CD8+ T-cell responses in melanoma patients

  2012cited by this paper
• Effect of Adjuvants on Responses to Skin Immunization by Microneedles Coated with Influenza Subunit Vaccine

  2012cited by this paper
• Towards tailored vaccine delivery: needs, challenges and perspectives.

  2012cited by this paper
• Adjuvanted, antigen loaded N-trimethyl chitosan nanoparticles for nasal and intradermal vaccination: adjuvant- and site-dependent immunogenicity in mice.

  2012cited by this paper
• Interleukin-10

  2012cited by this paper
• Chitosan-based drug nanocarriers: where do we stand?

  2012cited by this paper
• Nanocarriers for cytoplasmic delivery: cellular uptake and intracellular fate of chitosan and hyaluronic acid-coated chitosan nanoparticles in a phagocytic cell model.

  2011cited by this paper
• Effective transcutaneous immunization by antigen-loaded flexible liposome in vivo

  2011cited by this paper
• PPS nanoparticles as versatile delivery system to induce systemic and broad mucosal immunity after intranasal administration.

  2011cited by this paper
• Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles.

  2010cited by this paper
• Dual role of CpG as immune modulator and physical crosslinker in ovalbumin loaded N-trimethyl chitosan (TMC) nanoparticles for nasal vaccination.

  2010cited by this paper
• Chitosan-based nanoparticles for improving immunization against hepatitis B infection.

  2010cited by this paper
• Chitosan-based delivery systems for protein therapeutics and antigens.

  2010cited by this paper
• Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen.

  2010cited by this paper
• Nanoparticles for nasal vaccination.

  2009cited by this paper
• C3, C5, and factor B bind to chitosan without complement activation.

  2009cited by this paper
• Delivery by Cationic Gelatin Nanoparticles Strongly Increases the Immunostimulatory Effects of CpG Oligonucleotides

  2008cited by this paper
• Development and validation of HPLC method for imiquimod determination in skin penetration studies.

  2008cited by this paper
• Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles.

  2008cited by this paper
• Needle-free vaccine delivery

  2007cited by this paper
• N-trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: biological properties and immunogenicity in a mouse model.

  2007cited by this paper
• Needle-free vaccine delivery.

  2006cited by this paper
• Complement Activation by Core–Shell Poly(isobutylcyanoacrylate)–Polysaccharide Nanoparticles: Influences of Surface Morphology, Length, and Type of Polysaccharide

  2006cited by this paper
• Pathogen recognition and development of particulate vaccines: does size matter?

  2006cited by this paper
• Global health. The new world of global health.

  2006cited by this paper
• The New World of Global Health

  2006cited by this paper
• Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model.

  2005cited by this paper
• Mucosal delivery of bacterial antigens and CpG oligonucleotides formulated in biphasic lipid vesicles in pigs

  2005cited by this paper
• Intranasal delivery of chitosan-DNA vaccine generates mucosal SIgA and anti-CVB3 protection.

  2004cited by this paper
• Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice.

  2004cited by this paper
• Hepatitis B vaccines.

  2003cited by this paper
• Influence of the chain length of chitosan on complement activation

  2003cited by this paper
• Blood protein adsorption onto chitosan.

  2002cited by this paper
• Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential

  2002influential reference
• Mucosal immunization against hepatitis B virus by intranasal co-administration of recombinant hepatitis B surface antigen and recombinant cholera toxin B subunit as an adjuvant.

  2001cited by this paper
• Modulation of TH1 and TH2 cytokine production with the immune response modifiers, R-848 and imiquimod.

  1999cited by this paper
• Chitin and chitosan activate complement via the alternative pathway

  1998cited by this paper
• CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice.

  1998cited by this paper
• Cellular Requirements for Cytokine Production in Response to the Immunomodulators Imiquimod and S-27609

  1995influential reference
• Interleukin-10.

  1993cited by this paper
• Hepatitis B surface antigen. Role of lipids in maintaining the structural and antigenic properties of protein components.

  1990cited by this paper
• Hepatitis B Surface Antigen測定の改良法による再現性に関する検討

  1983cited by this paper
• Activation of the alternative complement pathway and generation of chemotactic factors by asbestos.

  1977cited by this paper

• Nanostructured Drug Delivery Systems in Immunotherapy: An Updated Overview of Nanotechnology-Based Therapeutic Innovations

  2024cites this paper
• Nanoemulsions and nanocapsules as carriers for the development of intranasal mRNA vaccines

  2024cites this paper
• Imiquimod powder for inhalation to stimulate innate immunity

  2024cites this paper
• Immunization with nanovaccines containing mutated K-Ras peptides and imiquimod aggravates heterotopic pancreatic cancer induced in mice

  2023cites this paper
• Antiviral polysaccharide and antiviral peptide delivering nanomaterials for prevention and treatment of SARS-CoV-2 caused COVID-19 and other viral diseases

  2023cites this paper
• Nanovaccines: A game changing approach in the fight against infectious diseases.

  2023cites this paper
• Dextran Nanocapsules with ω-3 in Their Nucleus: An Innovative Nanosystem for Imiquimod Transdermal Delivery

  2022cites this paper
• Phospholipid-Based Microemulsions for Cutaneous Imiquimod Delivery

  2022cites this paper
• Spatio-temporal delivery of both intra- and extracellular toll-like receptor agonists for enhancing antigen-specific immune responses

  2022cites this paper
• Experimental vaccination with nanoparticles containing Escherichia coli virulence factors

  2021cites this paper
• Chitin and chitosan as tools to combat COVID-19: A triple approach

  2021cites this paper
• Chitosan-Based Nanoparticles Against Viral Infections

  2021cites this paper
• Carboxymethyl-β-glucan/chitosan nanoparticles: new thermostable and efficient carriers for antigen delivery

  2021cites this paper
• Nanotechnologies for the delivery of biologicals: historical perspective and current landscape.

  2021cites this paper
• ‘Sweet as a Nut’: Production and Use of Nanocapsules made of Glycopolymer or Polysaccharide shell

  2021cites this paper
• Nanoparticles and trained immunity: glimpse into the future.

  2021cites this paper
• Evolution of Toll-like receptor 7/8 agonist therapeutics and their delivery approaches: From antiviral formulations to vaccine adjuvants

  2021cites this paper
• Nano‐Oncologicals: A Tortoise Trail Reaching New Avenues

  2021cites this paper
• Polymeric nanostructure vaccines: applications and challenges

  2020cites this paper
• Technological challenges in the preclinical development of an HIV nanovaccine candidate

  2020cites this paper
• Intranasal Subunit Vaccination Strategies Employing Nanomaterials and Biomaterials.

  2020cites this paper
• Biomedical Applications of Multifunctional Polymeric Nanocarriers: A Review of Current Literature

  2020cites this paper
• Characterisation of the Interaction among Oil-In-Water Nanocapsules and Mucin

  2020cites this paper
• Design of Polymeric Nanocapsules for Intranasal Vaccination against Mycobacterium Tuberculosis: Influence of the Polymeric Shell and Antigen Positioning

  2020cites this paper
• Engineering polymeric nanocapsules for an efficient drainage and biodistribution in the lymphatic system

  2019cites this paper
• Polysaccharide Nanoparticles Can Efficiently Modulate the Immune Response against an HIV Peptide Antigen

  2019cites this paper
• Design of polymeric nanocapsules to improve their lympho-targeting capacity.

  2019cites this paper
• Actinic keratosis and imiquimod: a review of novel carriers and patents

  2019cites this paper
• The size and composition of polymeric nanocapsules dictate their interaction with macrophages and biodistribution in zebrafish.

  2019cites this paper
• Intranasal Nanoparticulate Systems as Alternative Route of Drug Delivery.

  2019cites this paper
• Current and New Approaches for Mucosal Vaccine Delivery

  2019cites this paper
• An overview of biodegradable nanomaterials and applications in vaccines.

  2019cites this paper
• Systemic and mucosal humoral immune responses induced by the JY-adjuvanted nasal spray H7N9 vaccine in mice

  2018cites this paper
• Chitosan nanoencapsulation of flavonoids enhances their quorum sensing and biofilm formation inhibitory activities against an E.coli Top 10 biosensor.

  2018cites this paper
• Polymeric Nanocapsules for Vaccine Delivery: Influence of the Polymeric Shell on the Interaction With the Immune System

  2018cites this paper
• Mesoscopic Modeling of Encapsulation of Capsaicin 2 by Lecithin / Chitosan Liposomal Nanoparticles 3

  2018cites this paper
• Mesoscopic Modeling of the Encapsulation of Capsaicin by Lecithin/Chitosan Liposomal Nanoparticles

  2018cites this paper
• Bilayer polymeric nanocapsules: A formulation approach for a thermostable and adjuvanted E. coli antigen vaccine

  2018cites this paper
• Protamine Nanocapsules for the Development of Thermostable Adjuvanted Nanovaccines.

  2018cites this paper
• Engineering, on‐demand manufacturing, and scaling‐up of polymeric nanocapsules

  2018cites this paper
• Fatty Acid-Mimetic Micelles for Dual Delivery of Antigens and Imidazoquinoline Adjuvants.

  2017cites this paper
• Recent developments in nanocarrier-aided mucosal vaccination.

  2017cites this paper
• An investigation of the interactions between an E. coli bacterial quorum sensing biosensor and chitosan-based nanocapsules.

  2017cites this paper
• Gold-based nano-adjuvants

  2017cites this paper
• Advances on the formulation of proteins using nanotechnologies

  2017cites this paper
• Modulating the immune system through nanotechnology.

  2017cites this paper
• Nanoencapsulated capsaicin changes migration behavior and morphology of madin darby canine kidney cell monolayers

  2017cites this paper
• Physicochemical Properties, Biomolecular Corona, Bioactivity, and Pharmacology-Based Issues of Biopolymers: A Brief Overview: Letter in Response to an Opinion Article Published in Trends in Biotechnology: Wang, C. and Dong, L. (2015) Exploring 'New' Bioactivities of Polymers at the Nano-Bio Interfac

  2016cites this paper
• Evaluating the Interactions Between Proteins and Components of the Immune System with Polymer Nanoparticles

  2016cites this paper
• Synthesis of microcapsules using inverse emulsion periphery RAFT polymerization via SPG membrane emulsification

  2016cites this paper
• Potential of mannan or dextrin nanogels as vaccine carrier/adjuvant systems

  2016cites this paper
• Mucosal vaccine delivery: Current state and a pediatric perspective.

  2016cites this paper
• Recent advances in vaccine delivery.

  2016cites this paper
• Potential of Translationally Controlled Tumor Protein-Derived Protein Transduction Domains as Antigen Carriers for Nasal Vaccine Delivery.

  2016cites this paper
• A novel lipid nanoparticle adjuvant significantly enhances B cell and T cell responses to sub-unit vaccine antigens.

  2016cites this paper
• Developments in Methods for Measuring the Intestinal Absorption of Nanoparticle-Bound Drugs

  2016cites this paper
• Nasal immunization with mannan-decorated mucoadhesive HPMCP microspheres containing ApxIIA toxin induces protective immunity against challenge infection with Actinobacillus pleuropneumoiae in mice.

  2016cites this paper
• Chitosan Polysaccharide Suppress Toll Like Receptor Dependent Immune Response

  2015cites this paper
• Synthetic Nanoparticles for Vaccines and Immunotherapy.

  2015cites this paper
• Multi-enveloping of particulated antigens with biopolymers and immunostimulant polynucleotides

  2015cites this paper
• Protamine-based nanoparticles as new antigen delivery systems.

  2015cites this paper
• Hepatitis B virus large surface protein: function and fame.

  2015cites this paper
• hitosan-based mucosal adjuvants : Sunrise on the ocean

  2015cites this paper
• Polymer nanotechnology based approaches in mucosal vaccine delivery: challenges and opportunities.

  2015cites this paper
• Intranasal and oral vaccination with protein-based antigens: advantages, challenges and formulation strategies

  2015cites this paper
• Nanoengineering of vaccines using natural polysaccharides

  2015cites this paper
• Chitosan encapsulation modulates the effect of capsaicin on the tight junctions of MDCK cells

  2015cites this paper
• Intranasal formulations: promising strategy to deliver vaccines

  2014cites this paper
• Highly versatile immunostimulating nanocapsules for specific immune

  2014cites this paper
• Nanotechnology Approaches for Cancer Immunotherapy and Immunomodulation

  2014cites this paper
• Polysaccharide-Based Nanocarriers for Drug Delivery

  2014cites this paper
• Highly versatile immunostimulating nanocapsules for specific immune potentiation.

  2014cites this paper